Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five brokerages that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year target price […]
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) was the target of a large decrease in short interest in December. As of December 15th, there was short interest totalling 2,650,000 shares, a decrease of 16.7% from the November 30th total of 3,180,000 shares. Approximately 2.4% of the shares of the company are short sold. Based […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Free Report)’s stock price hit a new 52-week high during trading on Tuesday . The stock traded as high as $5.85 and last traded at $5.78, with a volume of 84835 shares traded. The stock had previously closed at $5.76. Wall Street Analysts Forecast Growth Several equities research analysts […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Free Report)’s stock price hit a new 52-week high on Tuesday . The stock traded as high as $5.85 and last traded at $5.78, with a volume of 84835 shares changing hands. The stock had previously closed at $5.76. Wall Street Analysts Forecast Growth AMRX has been the topic […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Free Report) shares traded down 7.4% during trading on Wednesday . The company traded as low as $3.97 and last traded at $4.02. 437,237 shares were traded during trading, a decline of 59% from the average session volume of 1,064,612 shares. The stock had previously closed at $4.34. Wall […]